Whether the panel decision “is contrary to the . . . decisions of the Supreme Court of the United States [in] . . . MedImmune Inc. v. Genetech, Inc., 549 U.S. 118 (2007); Cardinal Chem. Co. v. Morton Int’l Inc., 508 U.S. 83 (1993); and Altvater v. Freeman, 319 U.S. 359 (1943).”
